Apparent absence of aging and gender effects on serotonin 1A receptors in human neocortex and hippocampus
暂无分享,去创建一个
Donatella Marazziti | Giovanni B. Cassano | D. Marazziti | G. Cassano | A. Rossi | G. Giannaccini | A. Lucacchini | Gino Giannaccini | Alessandra Rossi | Antonio Lucacchini | A. Naccarato | Lionella Palego | L. Palego | Antonio G. Naccarato
[1] J. Glowinski,et al. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT , 1983, Nature.
[2] B. Winblad,et al. Effect of Age on Human Brain Serotonin (S‐1) Binding Sites , 1984, Journal of neurochemistry.
[3] P P Humphrey,et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.
[4] A. Hirano,et al. Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons , 1985, Annals of neurology.
[5] Anat Biegon,et al. Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem , 1990, Brain Research.
[6] M. Folstein,et al. EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.
[7] S. Peroutka,et al. Pharmacological Differentiation and Characterization of 5‐HT1A, 5‐HT1B, and 5‐HT1C Binding Sites in Rat Frontal Cortex , 1986, Journal of neurochemistry.
[8] B. Kirkpatrick,et al. Sexual dimorphism in the brain: It's worse than you thought , 1995, Biological Psychiatry.
[9] D. Neary,et al. Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease , 1983, Journal of neurochemistry.
[10] J. Barrett,et al. Psychopathology in the aged , 1980 .
[11] K. Lesch,et al. Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. , 1990, Life sciences.
[12] D. Blazer,et al. Depression in Late Life , 1989 .
[13] C. Tanaka,et al. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. , 1991, Life sciences.
[14] L. D. van de Kar,et al. Neuroendocrine Pharmacology of Serotonergic (5-HT) Neurons , 1991 .
[15] H. Ladinsky,et al. Localization and gene expression of serotonin1A (5HT1A) receptors in human brain postmortem , 1994, Brain Research.
[16] R. Hen,et al. 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates , 1994, Neurochemistry International.
[17] A. Gulati,et al. Aging and 3H-paroxetine binding in rat brain: effect of imipramine and tetrahydroacridine. , 1993, Life sciences.
[18] B. Bošković,et al. THE SITE OF ACTION OF ANTIPARKINSONISM DRUGS. , 1964, International journal of neuropharmacology.
[19] Lee N. Robins,et al. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study , 1990 .
[20] D. Morgan. The dopamine and serotonin systems during aging in human and rodent brain. A brief review , 1987, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[21] A. Biegon,et al. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. , 1989, Archives of general psychiatry.
[22] J. Palacios,et al. Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites , 1986, Brain Research.
[23] N. Sims,et al. Biochemical Evidence of Selective Nerve Cell Changes in the Normal Ageing Human and Rat Brain , 1983, Journal of neurochemistry.
[24] J. Marcusson,et al. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites , 1993, Brain Research.
[25] J. Vry,et al. 5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: Multiple mechanisms of action? , 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[26] I. Lucki,et al. 5-Hydroxytryptamine1A receptors and behavioral responses. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[27] J. Bockaert,et al. Serotonin 5-HT1 receptors mediate inhibition of cyclic AMP production in neurons. , 1986, European journal of pharmacology.
[28] F. Artaud,et al. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. , 1984, European journal of pharmacology.
[29] Anat Biegon,et al. Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol , 1991, Brain Research.
[30] R. Gorski,et al. Two sexually dimorphic cell groups in the human brain , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] D. Middlemiss,et al. Binding of the Novel Serotonin Agonist 8‐Hydroxy‐2‐(Di‐n‐Propylamino) Tetralin in Normal and Alzheimer Brain , 1986, Journal of neurochemistry.
[32] S. Pradhan. Central neurotransmitters and aging. , 1980, Life sciences.
[33] B. Winblad,et al. Preservation of 5-hydroxytryptamine1A receptor-G protein interactions in the cerebral cortex of patients with Alzheimer's disease , 1991, Neuroscience Letters.
[34] H. Ladinsky,et al. Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem , 1997, Neurochemistry International.